In conclusion, TTD is a natural ligand of NR4A1 that acts as an antagonist, and treatment with TTD inhibited pancreatic cancer cell growth in both cell culture and in vivo studies in part through the regulation of two NR4A1-dependent apoptotic pathways. Here, NR4A1 is linked to pancreatic neoplasm.